Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023

SELL
$4.89 - $12.27 $1,955 - $4,908
-400 Reduced 1.87%
21,000 $103,000
Q4 2022

Jan 24, 2023

SELL
$8.88 - $12.77 $1,776 - $2,554
-200 Reduced 0.93%
21,400 $230,000
Q3 2022

Oct 19, 2022

BUY
$8.24 - $12.56 $9,064 - $13,816
1,100 Added 5.37%
21,600 $202,000
Q2 2022

Jul 20, 2022

BUY
$7.45 - $13.84 $745 - $1,384
100 Added 0.49%
20,500 $197,000
Q4 2021

Jan 14, 2022

BUY
$11.99 - $18.14 $1,199 - $1,814
100 Added 0.49%
20,400 $248,000
Q3 2021

Oct 12, 2021

BUY
$11.55 - $16.06 $10,395 - $14,453
900 Added 4.64%
20,300 $314,000
Q2 2021

Jul 16, 2021

BUY
$12.38 - $29.19 $240,172 - $566,286
19,400 New
19,400 $277,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $262M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.